Skip to content
Latest Development in MS Treatment and Research episode artwork

Nov 18, 2014 10 min

Latest Development in MS Treatment and Research

from Picking Our Brain with Shepherd Center Hosted by Shepherd Center

Researchers are reporting exciting work under way to develop new treatments for multiple sclerosis. A number of clinical trials are under way at Shepherd Center and elsewhere. The U.S. Food and Drug Administration (FDA) has approved Plegridy™ (peginterferon beta-1a), a new treatment for people with relapsing forms of multiple sclerosis (RMS). Clinical trials show the drug reduces relapses, disability progression and brain lesions. MS management can be divided into three areas: relapse treatment, symptom management and disease modification. Listen in as Ben Thrower, M.D., discusses the latest developments in MS management at Shepherd Center.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Latest Development in MS Treatment and Research

0:00 10:23

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Picking Our Brain with Shepherd Center?

This episode is 10 minutes long.

When was this Picking Our Brain with Shepherd Center episode published?

This episode was published on November 18, 2014.

Can I download this Picking Our Brain with Shepherd Center episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.